Why the study?
Is epicardial adipose tissue thickness associated with angiographic thrombus burden and no-reflow in patients with NSTEMI undergoing primary PCI?
Is epicardial adipose tissue thickness associated with angiographic thrombus burden and no-reflow in patients with NSTEMI undergoing primary PCI?
Increased epicardial adipose tissue thickness is independently associated with higher angiographic thrombus burden and no-reflow in patients with NSTEMI undergoing primary PCI.
Answers are grounded in this paper and cite their sources.
May flag higher thrombus/no-reflow risk in NSTEMI PCI; hypothesis-generating and should not yet change practice.
We aimed to evaluate the relation among epicardial adipose tissue (EAT) thickness, angiographic presence of thrombus, and the no-reflow in the patients with non-ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The study population consisted of 229 patients. The EAT thickness and neutrophil to lymphocyte ratio (NLR) were significantly higher in the patients with coronary thrombus than in those without coronary thrombus (6.1 ± 1.1 vs 5.1 ± 1.3 mm, P < .001 and 3.4 ± 0.9 vs 2.5 ± 0.7, P < .001, respectively) and in the patients with no-reflow compared to patients with reflow. The EAT thickness was found to be correlated positively with the degree of the thrombus burden, NLR, and waist circumference and negatively with high-density lipoprotein cholesterol. Multivariate logistic regression analysis demonstrated that EAT thickness and NLR independently predicted coronary thrombus formation and no-reflow. We have suggested that EAT can play an important role in the pathophysiology of coronary thrombus formation and the no-reflow.
No takes yet. Share an insight, caveat, or question.
Bakırcı et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: